Clinical ink is a global life science technology company revolutionizing clinical trials by integrating cutting-edge data solutions and technology with patient-centered approaches. Founded in 2007, we help to address key industry challenges, such as optimizing recruitment, improving retention, and reducing the cost of bringing treatments to market. Supporting sponsors directly and through a network of CRO partners, our solutions support complex clinical trials across Oncology, CNS, Cardiometabolic and Rare Diseases via an advanced eSource platform designed to replace traditional Electronic Data Capture (EDC) systems. Our technology ecosystem includes eCOA (electronic Clinical Outcome Assessments), ePRO (Patient-Reported Outcomes), eConsent , telehealth solutions, and digital biomarkers. These tools enhance data precision, improve patient engagement, and streamline decentralized clinical trials. Clinical ink's innovations ensure real-time data collection from wearable sensors, and mobile applications, which promote compliance and patient retention while reducing costs and operational complexity. Our device-agnostic systems prioritize patient convenience, allowing participation from home or hybrid trial settings.
If you’ve ever lost sleep over delayed study enrollment, consider 1nHealth your new weighted blanket. 1nHealth fills studies through a simple philosophy: Don’t waste the power of…
Leveraging over 30 years of experience working with large biopharma, emerging biotech, CROs, and healthcare companies, the strategic advisors, executives, and subject matter…
Block Clinical is intently focused on streamlining the myriad of logistics involved in traditional, virtual, and hybrid clinical trials. From globally integrated patient…